Taking Wegovy and sertraline together: what the clinical evidence shows

Semaglutide (Wegovy) slows gastric emptying, which can alter how quickly oral medicines are absorbed — a factor that may be relevant when sertraline is taken at the same time of day.
No direct drug-drug interaction between semaglutide and sertraline appears in current UK prescribing references, but this does not mean the combination is without nuance.
Both medicines carry information about mood-related monitoring; your prescriber will consider your full psychiatric and physical history before approving treatment.
Telling your prescribing team about every medicine you already take (including sertraline) is essential before Wegovy is started or a dose is increased.

If you are already taking sertraline for depression or anxiety and your doctor has mentioned Wegovy for weight management, one of the first questions you are likely to ask is whether the two medicines are safe to take together. The short answer is that no specific pharmacokinetic interaction between semaglutide and sertraline has been identified in the clinical literature, but there are practical considerations worth understanding before you start. Both medicines affect how your body functions day to day, and because Wegovy is a prescription-only medicine requiring clinical assessment, any combination with another prescribed drug needs to be part of that conversation with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How semaglutide and sertraline interact in practice — the evidence reviewed

What the prescribing data actually shows about semaglutide and oral medicines

Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist licensed in the UK for weight management in adults whose BMI meets the relevant threshold. One of its well-documented mechanisms is that it slows the rate at which the stomach empties its contents into the small intestine. For most people this contributes to the feeling of fullness that makes eating less feel manageable. For people taking oral medicines, though, it raises a reasonable question: if food moves through the stomach more slowly, does medication move through more slowly too? The clinical answer, as summarised by the NHS medicines page for semaglutide, is that gastric emptying effects are most pronounced early in treatment and tend to settle. Studies conducted during Wegovy's development did examine its potential to affect the pharmacokinetics of other oral medicines, and no clinically significant interaction was identified with commonly co-prescribed drugs. Sertraline was not isolated as a specific concern in those studies. That said, prescribing references advise monitoring patients who take medicines with a narrow therapeutic index, and your prescriber will weigh that context for your individual situation. The STEP 1 trial, published in the New England Journal of Medicine, enrolled over 1,900 adults on semaglutide 2.4mg; participants in real-world use frequently take co-medications, which is why post-marketing surveillance and individual prescriber assessment remain important layers of safety on top of trial data.

Mood monitoring when sertraline and semaglutide overlap

Sertraline is a selective serotonin reuptake inhibitor prescribed for depression, generalised anxiety disorder, obsessive-compulsive disorder and other conditions. People taking it are, by definition, managing a mental health condition. When starting Wegovy, several things can happen in the first weeks that intersect with mental wellbeing: appetite changes can feel disorienting, nausea is common at the start, and some people experience fatigue or low mood as their body adjusts to the medicine. None of those effects are unique to people on sertraline, but they are worth naming plainly. The Wegovy Patient Information Leaflet and SmPC, available via the electronic Medicines Compendium, lists depressed mood and suicidal thoughts as effects that should prompt urgent contact with a healthcare professional, not because they are common, but because anyone on treatment for a mood disorder should know to act quickly if their mental state changes. A practical takeaway: keep your GP and your Wegovy prescriber both aware that you take sertraline. That communication loop is more protective than any single prescribing database check. Our detailed look at whether Wegovy and sertraline can be taken together covers the mood-monitoring question in full.

Routine, timing, and a small practical point worth knowing

People on sertraline typically take it at a consistent time each day, often in the morning with food, which is a common approach for tolerability. Wegovy is a once-weekly subcutaneous injection, so its administration timing does not compete with a daily tablet routine in the way that, say, two daily oral medicines might. That removes one layer of complexity. Keeping your Wegovy pen in the fridge door alongside other refrigerated items you open regularly is a simple way to build the weekly routine without needing a separate reminder system. What is worth noting is that if you ever switch from Wegovy injections to the newer oral semaglutide formulation, the morning-on-an-empty-stomach requirement for the tablet would need to be coordinated with when you take sertraline; that is a conversation for your prescriber rather than something to navigate alone. For a broader look at the Wegovy treatment overview, including its licensed dose schedule and eligibility criteria, we have covered those questions separately. People who want to understand the cost side of treatment can find an honest breakdown of Wegovy pricing in the UK on a dedicated page, which is also the one internal context where cost detail belongs. For anything regarding your specific combination of sertraline and semaglutide, the right step is a conversation with a clinician who can see your full medical history, and those who are exploring how to access Wegovy on line will find guidance on what a safe and regulated online prescribing process looks like. Speak to our prescribers through a free consultation via our weight-loss treatment page, and they will review your situation the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions